Format

Send to

Choose Destination
See comment in PubMed Commons below
South Med J. 2001 Nov;94(11):1112-7.

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension.

Author information

  • 1Research Service, Department of Veterans Affairs Medical Center, Boise, Idaho 83702, USA.

Abstract

BACKGROUND:

Increasing numbers of the adult population are using alternative or complementary health resources in the treatment of chronic medical conditions. Systemic hypertension affects more than 50 million adults and is one of the most common risk factors for cardiovascular morbidity and mortality. This study evaluates the antihypertensive effectiveness of oral coenzyme Q10 (CoQ), an over-the-counter nutritional supplement, in a cohort of 46 men and 37 women with isolated systolic hypertension.

METHODS:

We conducted a 12-week randomized, double-blind, placebo-controlled trial with twice daily administration of 60 mg of oral CoQ and determination of plasma CoQ levels before and after the 12 weeks of treatment.

RESULTS:

The mean reduction in systolic blood pressure of the CoQ-treated group was 17.8 +/- 7.3 mm Hg (mean +/- SEM). None of the patients exhibited orthostatic blood pressure changes.

CONCLUSIONS:

Our results suggest CoQ may be safely offered to hypertensive patients as an alternative treatment option.

PMID:
11780680
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center